Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence

P. Drevinek, E. Mahenthiralingam

. 2010 ; 16 (7) : 821-830.

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc12026768

Grantová podpora
NS10543 MZ0 CEP - Centrální evidence projektů

Burkholderia cepacia complex (Bcc) bacteria have gained notoriety as pathogens in cystic fibrosis (CF) because they are difficult to identify and treat, and also have the ability to spread between CF individuals. Of the 17 formally named species within the complex, Burkholderia multivorans and Burkholderia cenocepacia dominate in CF. Multilocus sequence typing has proven to be a very useful tool for tracing the global epidemiology of Bcc bacteria and has shown that B. cenocepacia strains with high transmissibility, such as the ET-12 strain (ST-28) and the Czech strain (ST-32), have spread epidemically within CF populations in Canada and Europe. The majority of research on the molecular pathogenesis of Bcc bacteria has focused on the B. cenocepacia ET-12 epidemic lineage, with gene mutation, genome sequence analysis and, most recently, global gene expression studies shedding considerable light on the virulence and antimicrobial resistance of this pathogen. These studies demonstrate that the ability of B. cenocepacia to acquire foreign DNA (genomic islands, insertion sequences and other mobile elements), regulate gene expression via quorum sensing, compete for iron during infection, and mediate antimicrobial resistance and inflammation via its membrane and surface polysaccharides are key features that underpin the virulence of different strains. With the wealth of molecular knowledge acquired in the last decade on B. cenocepacia strains, we are now in a much better position to develop strategies for the treatment of pathogenic colonization with Bcc and to answer key questions on pathogenesis concerning, for example, the factors that trigger the rapid clinical decline in CF patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12026768
003      
CZ-PrNML
005      
20170410121827.0
007      
ta
008      
120816s2010 fr f 000 0#eng||
009      
AR
024    7_
$a 10.1111/j.1469-0691.2010.03237.x $2 doi
035    __
$a (PubMed)20880411
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Dřevínek, Pavel, $u Paediatric Department, 2nd Medical School, Charles University, Prague, Czech Republic. pavel.drevinek@Lfmotol.cuni.cz $d 1975- $7 xx0075827
245    10
$a Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence / $c P. Drevinek, E. Mahenthiralingam
520    9_
$a Burkholderia cepacia complex (Bcc) bacteria have gained notoriety as pathogens in cystic fibrosis (CF) because they are difficult to identify and treat, and also have the ability to spread between CF individuals. Of the 17 formally named species within the complex, Burkholderia multivorans and Burkholderia cenocepacia dominate in CF. Multilocus sequence typing has proven to be a very useful tool for tracing the global epidemiology of Bcc bacteria and has shown that B. cenocepacia strains with high transmissibility, such as the ET-12 strain (ST-28) and the Czech strain (ST-32), have spread epidemically within CF populations in Canada and Europe. The majority of research on the molecular pathogenesis of Bcc bacteria has focused on the B. cenocepacia ET-12 epidemic lineage, with gene mutation, genome sequence analysis and, most recently, global gene expression studies shedding considerable light on the virulence and antimicrobial resistance of this pathogen. These studies demonstrate that the ability of B. cenocepacia to acquire foreign DNA (genomic islands, insertion sequences and other mobile elements), regulate gene expression via quorum sensing, compete for iron during infection, and mediate antimicrobial resistance and inflammation via its membrane and surface polysaccharides are key features that underpin the virulence of different strains. With the wealth of molecular knowledge acquired in the last decade on B. cenocepacia strains, we are now in a much better position to develop strategies for the treatment of pathogenic colonization with Bcc and to answer key questions on pathogenesis concerning, for example, the factors that trigger the rapid clinical decline in CF patients.
650    _2
$a infekce bakteriemi rodu Burkholderia $x komplikace $x epidemiologie $x mikrobiologie $7 D019121
650    _2
$a Burkholderia cenocepacia $x klasifikace $x genetika $x izolace a purifikace $x patogenita $7 D057508
650    _2
$a Burkholderia cepacia komplex $x klasifikace $x genetika $x izolace a purifikace $x patogenita $7 D042602
650    _2
$a cystická fibróza $x genetika $x mikrobiologie $7 D003550
650    _2
$a bakteriální léková rezistence $7 D024881
650    _2
$a exprese genu $7 D015870
650    _2
$a lidé $7 D006801
650    _2
$a rozptýlené repetitivní sekvence $7 D020071
650    _2
$a molekulární epidemiologie $7 D017720
650    _2
$a multilokusová sekvenční typizace $x metody $7 D058885
650    _2
$a mutace $7 D009154
650    _2
$a bakteriální polysacharidy $x fyziologie $7 D011135
650    _2
$a quorum sensing $7 D053038
650    _2
$a infekce dýchací soustavy $x komplikace $x epidemiologie $x mikrobiologie $7 D012141
650    _2
$a virulence $x genetika $7 D014774
651    _2
$a Kanada $x epidemiologie $7 D002170
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a přehledy $7 D016454
700    1_
$a Mahenthiralingam, Eshwar $u Cardiff School of Biosciences, Cardiff University, Cardiff, UK
773    0_
$w MED00001139 $t Clinical microbiology and infection the official publication of the European Society of Clinical Microbiology and Infectious Diseases $x 1469-0691 $g Roč. 16, č. 7 (2010), s. 821-830
856    41
$u https://pubmed.ncbi.nlm.nih.gov/20880411 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20170410122125 $b ABA008
999    __
$a ok $b bmc $g 948810 $s 784114
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2010 $b 16 $c 7 $d 821-830 $i 1469-0691 $m Clinical microbiology and infection $n Clin Microbiol Infect $x MED00001139
GRA    __
$a NS10543 $p MZ0
LZP    __
$b NLK113 $a Pubmed-20120816/11/01

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...